FilingReader Intelligence
SMS Pharmaceuticals reports Q1 net profit of INR 1,821m
August 9, 2025 at 08:19 AM UTC•By FilingReader AI
SMS Pharmaceuticals reported standalone net profit after tax of INR 1,820.75 lakhs for the quarter ended June 30, 2025, with total comprehensive income at INR 1,811.31 lakhs.
On a consolidated basis, net profit after tax was INR 1,871.47 lakhs, with total comprehensive income at INR 2,040.25 lakhs.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:SMSPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when SMS Pharmaceuticals publishes news
Free account required • Unsubscribe anytime